OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
Ken‐ichi Takayama, Aya Misawa, Takashi Suzuki, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 104
Ken‐ichi Takayama, Aya Misawa, Takashi Suzuki, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 104
Showing 1-25 of 104 citing articles:
TET-mediated active DNA demethylation: mechanism, function and beyond
Xiaoji Wu, Yi Zhang
Nature Reviews Genetics (2017) Vol. 18, Iss. 9, pp. 517-534
Closed Access | Times Cited: 1349
Xiaoji Wu, Yi Zhang
Nature Reviews Genetics (2017) Vol. 18, Iss. 9, pp. 517-534
Closed Access | Times Cited: 1349
Epigenetic modulations and lineage plasticity in advanced prostate cancer
Rongrong Ge, Zifan Wang, Rodolfo Montironi, et al.
Annals of Oncology (2020) Vol. 31, Iss. 4, pp. 470-479
Open Access | Times Cited: 155
Rongrong Ge, Zifan Wang, Rodolfo Montironi, et al.
Annals of Oncology (2020) Vol. 31, Iss. 4, pp. 470-479
Open Access | Times Cited: 155
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
DNA methylation methods: Global DNA methylation and methylomic analyses
Shizhao Li, Trygve O. Tollefsbol
Methods (2020) Vol. 187, pp. 28-43
Open Access | Times Cited: 138
Shizhao Li, Trygve O. Tollefsbol
Methods (2020) Vol. 187, pp. 28-43
Open Access | Times Cited: 138
Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells
Aya Misawa, Ken‐ichi Takayama, Tomohiko Urano, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 34, pp. 17861-17880
Open Access | Times Cited: 139
Aya Misawa, Ken‐ichi Takayama, Tomohiko Urano, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 34, pp. 17861-17880
Open Access | Times Cited: 139
TET2 coactivates gene expression through demethylation of enhancers
Lu Wang, Patrick A. Ozark, Edwin R. Smith, et al.
Science Advances (2018) Vol. 4, Iss. 11
Open Access | Times Cited: 103
Lu Wang, Patrick A. Ozark, Edwin R. Smith, et al.
Science Advances (2018) Vol. 4, Iss. 11
Open Access | Times Cited: 103
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
Ken‐ichi Takayama, Takashi Suzuki, Tomoaki Tanaka, et al.
Oncogene (2018) Vol. 37, Iss. 16, pp. 2165-2180
Closed Access | Times Cited: 95
Ken‐ichi Takayama, Takashi Suzuki, Tomoaki Tanaka, et al.
Oncogene (2018) Vol. 37, Iss. 16, pp. 2165-2180
Closed Access | Times Cited: 95
A review of the biological role of miRNAs in prostate cancer suppression and progression
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
International Journal of Biological Macromolecules (2021) Vol. 197, pp. 141-156
Closed Access | Times Cited: 89
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
International Journal of Biological Macromolecules (2021) Vol. 197, pp. 141-156
Closed Access | Times Cited: 89
Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer
Ken‐ichi Takayama, Takashi Suzuki, Tetsuya Fujimura, et al.
Molecular Cancer Research (2018) Vol. 16, Iss. 5, pp. 846-856
Open Access | Times Cited: 84
Ken‐ichi Takayama, Takashi Suzuki, Tetsuya Fujimura, et al.
Molecular Cancer Research (2018) Vol. 16, Iss. 5, pp. 846-856
Open Access | Times Cited: 84
The angiocrine Rspondin3 instructs interstitial macrophage transition via metabolic–epigenetic reprogramming and resolves inflammatory injury
Bisheng Zhou, Lissette Magana, Zhigang Hong, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1430-1443
Open Access | Times Cited: 81
Bisheng Zhou, Lissette Magana, Zhigang Hong, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1430-1443
Open Access | Times Cited: 81
Cancer epigenetics: Past, present and future
Jae Eun Lee, Mi‐Young Kim
Seminars in Cancer Biology (2021) Vol. 83, pp. 4-14
Closed Access | Times Cited: 71
Jae Eun Lee, Mi‐Young Kim
Seminars in Cancer Biology (2021) Vol. 83, pp. 4-14
Closed Access | Times Cited: 71
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 67-82
Open Access | Times Cited: 70
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 67-82
Open Access | Times Cited: 70
The microRNA-29 family: role in metabolism and metabolic disease
Louise T. Dalgaard, Anja E. Sørensen, Anandwardhan A. Hardikar, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 2, pp. C367-C377
Closed Access | Times Cited: 59
Louise T. Dalgaard, Anja E. Sørensen, Anandwardhan A. Hardikar, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 2, pp. C367-C377
Closed Access | Times Cited: 59
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
Shigekatsu Maekawa, Ryo Takata, Wataru Obara
Cancers (2024) Vol. 16, Iss. 3, pp. 523-523
Open Access | Times Cited: 11
Shigekatsu Maekawa, Ryo Takata, Wataru Obara
Cancers (2024) Vol. 16, Iss. 3, pp. 523-523
Open Access | Times Cited: 11
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
Yaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1496-1521
Open Access | Times Cited: 11
Yaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1496-1521
Open Access | Times Cited: 11
Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy
Mankgopo Magdeline Kgatle, Asgar Ali Kalla, Md. Mohaimenul Islam, et al.
Prostate Cancer (2016) Vol. 2016, pp. 1-11
Open Access | Times Cited: 70
Mankgopo Magdeline Kgatle, Asgar Ali Kalla, Md. Mohaimenul Islam, et al.
Prostate Cancer (2016) Vol. 2016, pp. 1-11
Open Access | Times Cited: 70
TET2 binds the androgen receptor and loss is associated with prostate cancer
Michael L. Nickerson, Shreya Das, Kate M. Im, et al.
Oncogene (2016) Vol. 36, Iss. 15, pp. 2172-2183
Open Access | Times Cited: 65
Michael L. Nickerson, Shreya Das, Kate M. Im, et al.
Oncogene (2016) Vol. 36, Iss. 15, pp. 2172-2183
Open Access | Times Cited: 65
miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers
Thomas Stefan Worst, Christopher Previti, Katja Nitschke, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 43-43
Open Access | Times Cited: 65
Thomas Stefan Worst, Christopher Previti, Katja Nitschke, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 43-43
Open Access | Times Cited: 65
Toshiro Migita, Ken‐ichi Takayama, Tomohiko Urano, et al.
Cancer Science (2017) Vol. 108, Iss. 10, pp. 2011-2021
Open Access | Times Cited: 62
TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells
Zhongxue Ye, Jie Li, Xi Han, et al.
Journal of Experimental & Clinical Cancer Research (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 61
Zhongxue Ye, Jie Li, Xi Han, et al.
Journal of Experimental & Clinical Cancer Research (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 61
TET repression and increased DNMT activity synergistically induce aberrant DNA methylation
Hideyuki Takeshima, Tohru Niwa, Satoshi Yamashita, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5370-5379
Open Access | Times Cited: 60
Hideyuki Takeshima, Tohru Niwa, Satoshi Yamashita, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5370-5379
Open Access | Times Cited: 60
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer
Anbarasu Kumaraswamy, Katherine R. Welker Leng, Thomas C. Westbrook, et al.
European Urology (2021) Vol. 80, Iss. 1, pp. 71-81
Open Access | Times Cited: 52
Anbarasu Kumaraswamy, Katherine R. Welker Leng, Thomas C. Westbrook, et al.
European Urology (2021) Vol. 80, Iss. 1, pp. 71-81
Open Access | Times Cited: 52
Epigenetics in prostate cancer: clinical implications
Vincenza Conteduca, Judy Hess, Yasutaka Yamada, et al.
Translational Andrology and Urology (2021) Vol. 10, Iss. 7, pp. 3104-3116
Open Access | Times Cited: 45
Vincenza Conteduca, Judy Hess, Yasutaka Yamada, et al.
Translational Andrology and Urology (2021) Vol. 10, Iss. 7, pp. 3104-3116
Open Access | Times Cited: 45
DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges
Yan‐Nan Liu, Yi Qin, Bin Wu, et al.
Reproductive Toxicology (2022) Vol. 111, pp. 11-19
Open Access | Times Cited: 30
Yan‐Nan Liu, Yi Qin, Bin Wu, et al.
Reproductive Toxicology (2022) Vol. 111, pp. 11-19
Open Access | Times Cited: 30
Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion
Xiaoliang Li, Chunlian Wu, Ying Shen, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 26, pp. 10059-10070
Open Access | Times Cited: 53
Xiaoliang Li, Chunlian Wu, Ying Shen, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 26, pp. 10059-10070
Open Access | Times Cited: 53
